C4 Therapeutics
CCCC
CCCC
100 hedge funds and large institutions have $152M invested in C4 Therapeutics in 2025 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 19 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
8.56% more ownership
Funds ownership: 73.82% → 82.38% (+8.6%)
3% more funds holding
Funds holding: 97 → 100 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
100
Holding in Top 10
1
Calls
$738K
Puts
$152K
Top Buyers
| 1 | +$22.4M | |
| 2 | +$19M | |
| 3 | +$14.4M | |
| 4 |
Morgan Stanley
New York
|
+$9.5M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.99M |
Top Sellers
| 1 | -$9.07M | |
| 2 | -$7.7M | |
| 3 | -$2M | |
| 4 |
Millennium Management
New York
|
-$1.77M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$1.2M |
